Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - CAD ($)
Nov. 30, 2018
Nov. 30, 2017
Current    
Cash $ 6,641,877 $ 1,897,061
Accounts receivable, net (Note 4) 239,063 689,619
Investment tax credits 998,849 636,489
Prepaid expenses, sundry and other assets 586,794 225,092
Inventory (Note 3) 251,651 115,667
Current Assets 8,718,234 3,563,928
Deferred offering costs (Note 10) 0 565,302
Property and equipment, net (Note 5) 2,755,993 3,267,551
Assets 11,474,227 7,396,781
Current    
Accounts payable 2,643,437 2,060,084
Accrued liabilities (Note 6) 353,147 782,369
Employee costs payable (Note 8) 222,478 214,980
Convertible debentures (Note 7) 1,790,358 1,290,465
Deferred revenue (Note 3) 300,000 300,000
Current Liabilities 5,309,420 4,647,898
Deferred revenue (Note 3) 2,062,500 2,362,500
Liabilities 7,371,920 7,010,398
Shareholders' equity    
Capital stock (Note 10) authorized, unlimited common shares without par value, unlimited preference shares issued and outstanding 18,252,243 common shares (November 30, 2017 - 3,470,451) 44,327,952 35,290,034
Additional paid-in capital 45,110,873 36,685,387
Accumulated other comprehensive income 284,421 284,421
Accumulated deficit (85,620,939) (71,873,459)
Stockholders' Equity 4,102,307 386,383
Contingencies (Note 16)
Liabilities and Stockholders' Equity $ 11,474,227 $ 7,396,781